Trademark: 85261936
Word
JOVOLA
Status
Dead
Status Code
710
Status Date
Friday, July 16, 2021
Serial Number
85261936
Registration Number
4651130
Registration Date
Tuesday, December 9, 2014
Mark Type
4000
Filing Date
Wednesday, March 9, 2011
Published for Opposition
Tuesday, September 23, 2014
Cancellation Date
Friday, July 16, 2021

Trademark Owner History

Classifications
5 Pharmaceutical preparations, namely, pharmaceutical preparations and substances for the treatment of skin disorders, diseases, conditions and ailments; pharmaceutical preparations and products for use in dermatology; antifungal preparations; pharmaceutical preparations and substances for the treatment of eye disorders, diseases, conditions and ailments; pharmaceutical preparations and products for ophthalmological use; pharmaceutical preparations and substances for the treatment of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety, depression, depressive disorders and mental illness; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardiovascular system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of Parkinson's disease; pharmaceutical preparations and substances for the prevention, treatment and alleviation of Huntington's disease; pharmaceutical preparations and substances for the prevention, treatment and alleviation of amyotropic lateral sclerosis; pharmaceutical preparations and substances for the prevention, treatment and alleviation of Alzheimer's disease; pharmaceutical preparations and substances for the prevention, treatment and alleviation of Tourette Syndrome; pharmaceutical preparations and substances for the prevention, treatment and alleviation of epilepsy; pharmaceutical preparations and substances for the prevention, treatment and alleviation of multiple sclerosis; pharmaceutical preparations and substances for the prevention, treatment and alleviation of cardio-pulmonary disorders, diseases, conditions, and ailments; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions, and ailments of the circulatory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension, high blood pressure, heart filure and ventricular dysfunction; pharmaceutical preparations and substances for the prevention, treatment and alleviation of metabolic disorders, diseases, conditions and ailments; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of viral and infectious diseases; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of central nervous system disorders, diseases, conditions and ailments, namely, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, cerebral palsy, insomnia, mood disorders, bipolar disorder, seizure disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; pharmaceutical preparations for the treatment of immunologic diseases, namely, auto immune motility diseases, immunologic deficiency syndromes, auto immune diseases, Acquired Immune Deficiency Syndrome (AIDS), hypersensitivity, allergies, tumors of the immunological organs; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculoskeletal system, namely, bone diseases and bone degenerative conditions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for the treatment of polycystic ovary syndrome; pharmaceutical preparations and substances for the treatment of infertility; metformin; diltiazem; tramadol; carvedilol; bupropion; metoprolol; citalopram; zolpidem; fluoxetine; venlafaxine; lorazepam; and sumatriptan
Color is not claimed as a feature of the mark.

Trademark Events
Jul 16, 2021
Cancelled Sec. 8 (6-Yr)
May 3, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
May 3, 2020
Teas Change Of Correspondence Received
May 3, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
May 3, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 3, 2020
Teas Change Of Owner Address Received
Dec 9, 2019
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Jul 10, 2019
Assignment Of Ownership Not Updated Automatically
Mar 20, 2019
Automatic Update Of Assignment Of Ownership
Oct 16, 2018
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 16, 2018
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 21, 2018
Automatic Update Of Assignment Of Ownership
Jan 11, 2017
Automatic Update Of Assignment Of Ownership
Mar 3, 2016
Teas Change Of Correspondence Received
Jan 21, 2015
Assignment Of Ownership Not Updated Automatically
Dec 9, 2014
Registered-Principal Register
Sep 23, 2014
Official Gazette Publication Confirmation E-Mailed
Sep 23, 2014
Published For Opposition
Sep 3, 2014
Notification Of Notice Of Publication E-Mailed
Aug 19, 2014
Law Office Publication Review Completed
Aug 18, 2014
Approved For Pub - Principal Register
Jul 30, 2014
Teas/Email Correspondence Entered
Jul 30, 2014
Correspondence Received In Law Office
Jul 30, 2014
Teas Response To Office Action Received
Feb 14, 2014
Notification Of Non-Final Action E-Mailed
Feb 14, 2014
Non-Final Action E-Mailed
Feb 14, 2014
Non-Final Action Written
Jan 22, 2014
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 22, 2014
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 15, 2014
Lie Checked Susp - To Atty For Action
Jul 13, 2013
Report Completed Suspension Check Case Still Suspended
Jan 9, 2013
Report Completed Suspension Check Case Still Suspended
Aug 1, 2012
Assignment Of Ownership Not Updated Automatically
Jul 6, 2012
Notification Of Letter Of Suspension E-Mailed
Jul 6, 2012
Letter Of Suspension E-Mailed
Jul 6, 2012
Suspension Letter Written
Jun 27, 2012
Teas/Email Correspondence Entered
Jun 26, 2012
Correspondence Received In Law Office
Jun 26, 2012
Teas Response To Suspension Inquiry Received
Jun 27, 2012
Report Completed Suspension Check Case Still Suspended
Jun 27, 2012
Assigned To Lie
Dec 15, 2011
Notification Of Letter Of Suspension E-Mailed
Dec 15, 2011
Letter Of Suspension E-Mailed
Dec 15, 2011
Suspension Letter Written
Dec 15, 2011
Teas/Email Correspondence Entered
Dec 15, 2011
Correspondence Received In Law Office
Dec 15, 2011
Assigned To Lie
Dec 9, 2011
Teas Response To Office Action Received
Jun 9, 2011
Notification Of Non-Final Action E-Mailed
Jun 9, 2011
Non-Final Action E-Mailed
Jun 9, 2011
Non-Final Action Written
Jun 9, 2011
Assigned To Examiner
Apr 6, 2011
Automatic Update Of Assignment Of Ownership
Mar 14, 2011
New Application Office Supplied Data Entered In Tram
Mar 12, 2011
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24